HK1105947A1 - Trpv1 agonists, formulations containing them and uses thereof trpv1 - Google Patents
Trpv1 agonists, formulations containing them and uses thereof trpv1Info
- Publication number
- HK1105947A1 HK1105947A1 HK07111192.6A HK07111192A HK1105947A1 HK 1105947 A1 HK1105947 A1 HK 1105947A1 HK 07111192 A HK07111192 A HK 07111192A HK 1105947 A1 HK1105947 A1 HK 1105947A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trpv1
- sub
- formulations containing
- agonists
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
- C07C303/46—Separation; Purification from by-products of refining mineral oils with sulfuric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001566A ITMI20041566A1 (it) | 2004-07-30 | 2004-07-30 | "trpv1 agonisti, formulazioni che li contengono e loro usi" |
PCT/EP2005/007292 WO2006010445A1 (en) | 2004-07-30 | 2005-07-06 | Trpv1 agonists, formulations containing them and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1105947A1 true HK1105947A1 (en) | 2008-02-29 |
Family
ID=34979120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07111192.6A HK1105947A1 (en) | 2004-07-30 | 2007-10-17 | Trpv1 agonists, formulations containing them and uses thereof trpv1 |
Country Status (19)
Country | Link |
---|---|
US (1) | US7429673B2 (da) |
EP (1) | EP1773757B1 (da) |
JP (1) | JP4819810B2 (da) |
KR (1) | KR101206571B1 (da) |
CN (1) | CN101006047B (da) |
AT (1) | ATE524433T1 (da) |
AU (1) | AU2005266684B2 (da) |
CA (1) | CA2575341C (da) |
DK (1) | DK1773757T3 (da) |
ES (1) | ES2370029T3 (da) |
HK (1) | HK1105947A1 (da) |
IL (1) | IL181024A (da) |
IT (1) | ITMI20041566A1 (da) |
NO (1) | NO338341B1 (da) |
PL (1) | PL1773757T3 (da) |
PT (1) | PT1773757E (da) |
RU (1) | RU2379282C2 (da) |
SI (1) | SI1773757T1 (da) |
WO (1) | WO2006010445A1 (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
JP5562865B2 (ja) | 2007-12-17 | 2014-07-30 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Trpv1のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター |
KR101034299B1 (ko) * | 2008-12-02 | 2011-05-16 | 고려대학교 산학협력단 | Trpv3 활성 조절 약물 및 이의 활용 |
KR101034300B1 (ko) * | 2008-12-02 | 2011-05-16 | 고려대학교 산학협력단 | Trpv3 활성 억제 약물 및 이의 활용 |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
EP3485881B1 (en) | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
EP2531510B1 (en) | 2010-02-01 | 2014-07-23 | Novartis AG | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
ES2527849T3 (es) | 2010-02-02 | 2015-01-30 | Novartis Ag | Derivados de ciclohexilamida como antagonistas del receptor de CRF |
EP2557947A1 (en) | 2010-04-14 | 2013-02-20 | Altria Client Services Inc. | Preformed smokeless tobacco product |
PL2629610T3 (pl) | 2010-07-27 | 2018-02-28 | Flex Pharma, Inc. | Sposoby i kompozycje do zapobiegania i zmniejszania kurczy mięśni i do regeneracji po nerwowo-mięśniowym podrażnieniu i zmęczeniu po ćwiczeniach fizycznych |
US10799548B2 (en) | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
JP6833811B2 (ja) | 2015-08-03 | 2021-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 荷電イオンチャネル遮断薬及び使用方法 |
WO2018136943A1 (en) | 2017-01-23 | 2018-07-26 | Flex Pharma, Inc. | Compositions and methods affecting exercise performance |
CA3129089A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Ester substituted ion channel blockers and methods for use |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
WO2020185881A1 (en) | 2019-03-11 | 2020-09-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
JP2023500891A (ja) | 2019-11-06 | 2023-01-11 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
EP4054586A4 (en) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
WO2021183639A1 (en) | 2020-03-11 | 2021-09-16 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
RU2755206C1 (ru) | 2020-05-20 | 2021-09-14 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство пролонгированного анальгетического действия и лекарственный препарат на его основе |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4493848A (en) * | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
FR2619810B1 (fr) * | 1987-09-02 | 1990-01-05 | Hoechst France | Nouveaux monomeres ethyleniques polyfonctionnels |
IT1302264B1 (it) * | 1998-09-24 | 2000-09-05 | Innovet Italia Srl | Derivati a struttura n-acil vanillinamidica in grado di attivare irecettori periferici dei cannabinoidi |
JP2004182674A (ja) * | 2002-12-05 | 2004-07-02 | Kureha Chem Ind Co Ltd | バニリル脂肪酸アミドを含む抗腫瘍医薬組成物 |
-
2004
- 2004-07-30 IT IT001566A patent/ITMI20041566A1/it unknown
-
2005
- 2005-07-06 ES ES05770295T patent/ES2370029T3/es active Active
- 2005-07-06 CA CA2575341A patent/CA2575341C/en not_active Expired - Fee Related
- 2005-07-06 AT AT05770295T patent/ATE524433T1/de active
- 2005-07-06 RU RU2007103344/04A patent/RU2379282C2/ru not_active IP Right Cessation
- 2005-07-06 CN CN2005800256040A patent/CN101006047B/zh not_active Expired - Fee Related
- 2005-07-06 SI SI200531416T patent/SI1773757T1/sl unknown
- 2005-07-06 US US11/658,737 patent/US7429673B2/en not_active Expired - Fee Related
- 2005-07-06 PL PL05770295T patent/PL1773757T3/pl unknown
- 2005-07-06 AU AU2005266684A patent/AU2005266684B2/en not_active Ceased
- 2005-07-06 JP JP2007522950A patent/JP4819810B2/ja not_active Expired - Fee Related
- 2005-07-06 EP EP05770295A patent/EP1773757B1/en not_active Not-in-force
- 2005-07-06 WO PCT/EP2005/007292 patent/WO2006010445A1/en active Application Filing
- 2005-07-06 DK DK05770295.3T patent/DK1773757T3/da active
- 2005-07-06 PT PT05770295T patent/PT1773757E/pt unknown
- 2005-07-06 KR KR1020077001812A patent/KR101206571B1/ko not_active IP Right Cessation
-
2007
- 2007-01-29 NO NO20070531A patent/NO338341B1/no not_active IP Right Cessation
- 2007-01-29 IL IL181024A patent/IL181024A/en not_active IP Right Cessation
- 2007-10-17 HK HK07111192.6A patent/HK1105947A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2005266684A1 (en) | 2006-02-02 |
RU2007103344A (ru) | 2008-08-10 |
JP2008508202A (ja) | 2008-03-21 |
ATE524433T1 (de) | 2011-09-15 |
KR20070039078A (ko) | 2007-04-11 |
AU2005266684B2 (en) | 2012-05-10 |
EP1773757A1 (en) | 2007-04-18 |
CA2575341C (en) | 2014-09-23 |
IL181024A (en) | 2011-12-29 |
US7429673B2 (en) | 2008-09-30 |
NO338341B1 (no) | 2016-08-08 |
IL181024A0 (en) | 2007-07-04 |
KR101206571B1 (ko) | 2012-11-29 |
CA2575341A1 (en) | 2006-02-02 |
ES2370029T3 (es) | 2011-12-12 |
PT1773757E (pt) | 2011-10-27 |
PL1773757T3 (pl) | 2012-02-29 |
SI1773757T1 (sl) | 2011-12-30 |
CN101006047B (zh) | 2010-08-11 |
JP4819810B2 (ja) | 2011-11-24 |
ITMI20041566A1 (it) | 2004-10-30 |
WO2006010445A1 (en) | 2006-02-02 |
DK1773757T3 (da) | 2011-11-21 |
RU2379282C2 (ru) | 2010-01-20 |
EP1773757B1 (en) | 2011-09-14 |
CN101006047A (zh) | 2007-07-25 |
NO20070531L (no) | 2007-04-30 |
US20080132573A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL181024A0 (en) | Trpv1 agonists, formulations containing them and uses thereof | |
UA84208C2 (en) | Tetraazabenzo(e)azulene derivatives and analogs thereof | |
CA2495967A1 (fr) | Nouveau procede de synthese et nouvelle forme cristalline de l'agomelatine ainsi que les compositions pharmaceutiques qui la contiennent | |
TW200612920A (en) | Novel imidazolidine derivatives | |
NO20075809L (no) | DNA-PK inhibitorer | |
IL185275A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
TN2010000091A1 (en) | Substituted pyrazole derivative | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
WO2006084017A3 (en) | Phenyl-substituted pyrimidine compounds useful as kinase inhibitors | |
MA31763B1 (fr) | Inhibiteurs de kinase de type polo | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
MXPA05010824A (es) | Compuestos biciclicos como antagonistas del receptor nr2b. | |
MX2007007025A (es) | Nuevos derivados de hidantoina como inhibidores de metaloproteinasa. | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
SE0200919D0 (sv) | Chemical compounds | |
WO2005097100A3 (en) | Antibacterial agents | |
ATE505462T1 (de) | Neue biologischaktive molekü le | |
MXPA06000986A (es) | Compuestos. | |
SE0403085D0 (sv) | Novel componds | |
GB0512284D0 (en) | Organic compounds | |
DK1899331T3 (da) | Homomorpholinoxazolidnoner som antibakterielle midler | |
GB0215392D0 (en) | Chemical compounds | |
DE60100539D1 (en) | Tosylprolin-derivate als thymidylat-synthase inhibitoren | |
WO2007027719A3 (en) | Lisofylline analogues and their pharmeacuetical uses | |
TNSN07300A1 (en) | 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170706 |